|
Welcome to the second issue of PharmaView!
Pharmaceutical
Marketers are facing increasing pressures: increasing competition; squeezed
margins; shrinking budgets; more to do and less time to do it. It’s becoming
difficult to work any harder, and of course it's always better to work smarter.
Therefore we bring you the PharmaView.
PharmaView
is a biweekly educational and informative newsletter for improving readers’ marketing
knowledge and reporting the latest news in the pharma industry. It also provides
great opportunities to exchange ideas, network and be recognized among your
peers in the industry.
Through
PharmaView, you can:
Learn peer’s
experience in pharma marketing
Stay in touch with
what’s happening in pharmaceutical marketing today
Be on the
pioneering edge of pharmaceutical marketing
Have networking /
idea exchange opportunities
About Us
Integrating local
knowledge with international perspective,
Consultech Co. Ltd.
offers its clients and prospects one-lstop solutions with sales
and marketing consultancy, advertising and promotion strategies.
Consultech is an affiliate
company of Omnicom, the world's largest advertising and communications
holding company.
Bayer
thrombosis drug performs well in two studies
An experimental
thrombosis pill from Bayer AG, seen by analysts as the German group's most
important pipeline asset, has produced promising results in two clinical trials,
researchers said on Tuesday.
Sep 05, 2006
Vaccine "could cut cervical cancer deaths 76 pct"
GlaxoSmithKline's experimental vaccine
against a virus that causes cervical cancer could cut the number of cases and
deaths from the illness by up to 76 percent, the drug company said on Monday.
Sep 04,
06
FDA Approves First Generic Ciprofloxacin Injection,
USP
The Food and Drug
Administration today approved several Abbreviated New Drug Applications (ANDAs)
for generic versions of Bayer Corporation Pharmaceutical Division's CIPRO I.V.,
a drug to treat certain bacterial infections. This approval is an important step
in the agency's effort to increase the availability of lower-cost generic
medications.
Sep 03, 2006
From Managing Pills to Managing Brands
Most people in the pharmaceutical
industry firmly believe that successful drugs are the result of breakthrough
science. Drug companies have notoriously high R&D budgets, and the output of
their new product development tends to be prolific.
Sep 04,
2006
Launching a Blockbuster
Blockbusters are not
discovered, they are built! With that premise, a marketing executive summed up
the challenge of would-be players in the high-potential
pharmaceuticals' game.
Aug 30, 2006
Pfizer Wins Norvasc Patent Challenge by Generic Manufacturer Synthon
Pfizer Inc said
today that a federal court in the Middle District of North Carolina has upheld
the company's U.S. patent covering amlodipine besylate, the active ingredient in
Norvasc, the world's most-prescribed branded medicine for treating hypertension.
The patent had been challenged by the generic manufacturer, Synthon
Pharmaceuticals.
Sept 01, 2006
Some arthritis drugs may protect the heart
In patients with
rheumatoid arthritis, use of disease-lmodifying antirheumatic drugs, or DMARDs,
seems to lower the increased risk of cardiovascular disease associated with
rheumatoid arthritis, research suggests.
Aug
31, 2006
Please feel free to offer
your opinions and advices about PharmaView in order to better our
services. Should you have any comments, or if you want to unsubscribe from PharmaView, please send us an
email: pharmaview@Consultech.com.cn
. Thank you!
|
